Irvine, Calif. — The California Institute for Regenerative Medicine (CIRM) has awarded a UC Irvine neuroscientist $4.6 million to advance studies of a novel immunotherapy that holds the potential to revolutionize cancer treatment by targeting all major cancer types. The grant for $4,581,144 was awarded to Michael Demetriou, MD, PhD…
